文献速递淋巴瘤

1777例霍奇金淋巴瘤患者与6166名匹配对照者的长期生活质量研究

Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators.
PubMed 文献 · Am J Hematol · 2026-04-18

丹麦全国横断面研究比较霍奇金淋巴瘤(HL)幸存者与一般人群对照的长期生活质量(QoL)。共1777例HL患者和6166名匹配对照者完成问卷,按诊断后时间分层分析。HL组在各时间段的QoL均显著低于对照,差异在诊断后>10年仍具临床意义,疲劳和呼吸困难最突出。

要点

  • HL幸存者诊断后0-5年、>5-10年、>10年的QoL均显著低于匹配对照。
  • 诊断>10年后HL组与对照组的QoL差异仍具临床重要性。
  • 最突出的症状为疲劳和呼吸困难,需多学科幸存者照护。

核心结论

  • 霍奇金淋巴瘤患者与一般人群相比存在生活质量下降,即使诊断后超过10年差异仍具临床相关性。

研究设计与样本

  • 丹麦全国横断面研究,1777例HL患者按1:10匹配6166名一般人群对照。
  • 使用HeartQoL、QLQ-C30、SF-36和EQ-5D问卷评估生活质量。
  • 采用线性回归调整性别和年龄,按诊断后时间(0-5、>5-10、>10年)分层分析。

主要发现

  • HL组与对照组的平均差异(MD)在诊断后0-5、>5-10、>10年分别为:HeartQoL -0.27、-0.28、-0.24;QLQ-C30汇总评分 -7.4、-7.6、-5.6分;SF-36躯体成分汇总 -4.5、-4.9、-4.2分;EQ-5D指数 -0.05、-0.05、-0.04。
  • HL组与对照组的相对差异从基线至诊断后>10年有所减小,但差异仍具临床重要性。
  • 最突出的症状为疲劳和呼吸困难。

临床怎么用

  • 对HL幸存者应进行长期生活质量监测,关注疲劳和呼吸困难等症状。
  • 建议采用多学科方法提供幸存者照护,即使诊断后超过10年仍需关注生活质量下降。

局限性

  • 横断面设计无法推断因果关系。
  • 应答率较低(HL患者42%,对照14%),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Survival has improved substantially for patients with Hodgkin lymphoma (HL), but long-term quality of life (QoL) remains incompletely understood. This was a Danish, nationwide, cross-sectional study of QoL among persons with a diagnosis of HL matched 1:10 to general population comparators. Questionnaires included the HeartQoL, the European Organization for Research and Treatment of Cancer Quality of Life Core-30 (QLQ-C30), the Short Form-36 (SF-36), and the EuroQoL Health Questionnaire (EQ-5D). Mean differences (MD) were estimated using linear regression adjusted for sex and age, and stratified by time since diagnosis (0-5, > 5-10, and > 10 years). Overall, 1777 patients with HL (42% of 4156 invited) and 6166 matched comparators (14% of 41 558 invited) responded, and median age was similar (HL: 59, comparators: 61). Most had classical HL (92%). HL groups had consistently and significantly lower QoL than their respective comparators, with 0-5, > 5-10, and > 10 years post-diagnosis MDs of -0.27, -0.28, and -0.24 for the HeartQoL, -7.4, -7.6, and -5.6 points for the QLQ-C30 summary score, -4.5, -4.9, and -4.2 points for the SF-36 physical component summary, and -0.05, -0.05, and -0.04 for the EQ-5D index. The relative difference between the HL group and comparators decreased from baseline to > 10 years post-diagnosis, but differences remained clinically important. The most pronounced symptoms were fatigue and dyspnea. To summarize, persons with HL experience reductions in QoL compared with the general population, even > 10 years post-diagnosis. The observed differences were clinically relevant within several domains and emphasize the need for a multidisciplinary approach to survivorship care.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Godtfredsen SJ, Baech J, Andersen MP, et al. Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators. Am J Hematol. 2026. PMID: 41999561. doi:10.1002/ajh.70331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。